[1]
|
Silverstein J M. Need for improved monitoring in patients with acromegaly[J]. Endocr Connect,2015,4(4):R59-R67. doi: 10.1530/EC-15-0064
|
[2]
|
Vijayakumar R,Wu Y J,Sun H,et al. Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat diet–induced metabolic deterioration[J]. Diabetes,2012,61(1):94-103. doi: 10.2337/db11-0814
|
[3]
|
Katznelson L,Laws E R,Jr,et al. Acromegaly:An endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2014,99(11):3933-3951. doi: 10.1210/jc.2014-2700
|
[4]
|
Colao A,Ferone D,Marzullo P,et al. Systemic complications of acromegaly:Epidemiology,pathogenesis,and management[J]. Endocr Rev,2004,25(1):102-152. doi: 10.1210/er.2002-0022
|
[5]
|
M H I,C R R,D G G. Factors influencing mortality in acromegaly[J]. J Clin Endocrinol Metab,2004,89(2):667-674. doi: 10.1210/jc.2003-031199
|
[6]
|
Foss M C,Saad M J,Paccola G M,et al. Peripheral glucose metabolism in acromegaly[J]. J Clin Endocrinol Metab,1991,72(5):1048-1053. doi: 10.1210/jcem-72-5-1048
|
[7]
|
Cheng S,Gomez K,Serri O,et al. The role of diabetes in acromegaly associated neoplasia[J]. PLoS One,2015,10(5):e0127276. doi: 10.1371/journal.pone.0127276
|
[8]
|
Andersen M. Management of endocrine disease:GH excess:Diagnosis and medicaltherapy[J]. Eur J Endocrinol,2014,170(1):R31-R41. doi: 10.1530/EJE-13-0532
|
[9]
|
Bartke A,Sun L Y,Longo V. Somatotropic signaling:Trade-offs between growth,reproductive development,and longevity[J]. Physiol Rev,2013,93(2):571-598. doi: 10.1152/physrev.00006.2012
|
[10]
|
Young J A,List E O,Kopchick J J. Deconstructing the growth hormone receptor (GHR):Physical and metabolic phenotypes of tissue-specific GHR gene-disrupted mice[J]. Prog Mol Biol Transl Sci,2016,138(17):27-39.
|
[11]
|
Liu J L,Coschigano K T,Robertson K,et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice[J]. Am J Physiol Endocrinol Metab,2004,287(3):E405-E413. doi: 10.1152/ajpendo.00423.2003
|
[12]
|
Guo Y,Lu Y,Houle D,et al. Pancreatic islet-specific expression of an insulin-like growth factor-i transgene compensates islet cell growth in growth hormone receptor gene-deficient mice[J]. Endocrinology,2005,146(6):2602-2609. doi: 10.1210/en.2004-1203
|
[13]
|
Klover P,Hennighausen L. Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle:A role for autocrine/paracrine insulin-like growth factor I[J]. Endocrinology,2007,148(4):1489-1497. doi: 10.1210/en.2006-1431
|
[14]
|
Maedler K,Bonkowski M S,Dominici F P,et al. Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity[J]. PLoS ONE,2009,4(2):e4567. doi: 10.1371/journal.pone.0004567
|
[15]
|
Gaubitz C,Oliveira T M,Prouteau M,et al. Molecular basis of the rapamycin insensitivity of target of rapamycin complex 2[J]. Mol Cell,2015,58(6):977-988. doi: 10.1016/j.molcel.2015.04.031
|
[16]
|
Fang Y,Hill C M,Darcy J,et al. Effects of rapamycin on growth hormone receptor knockout mice[J]. Proc Natl Acad Sci U S A,2018,115(7):E1495-E1503. doi: 10.1073/pnas.1717065115
|
[17]
|
Sesti G,Federici M,Hribal M L,et al. Defects of the insulin receptor substrate(IRS)system in human metabolic disorders[J]. FASEB J,2001,15(12):2099-2111. doi: 10.1096/fj.01-0009rev
|
[18]
|
Gual P,Le Marchand-Brustel Y,Tanti J-F. Positive and negative regulation of insulin signaling through IRS-1phosphorylation[J]. Biochimie,2005,87(1):99-109. doi: 10.1016/j.biochi.2004.10.019
|
[19]
|
Smith T R,Elmendorf J S,David T S,et al. Growth hormone-induced insulin resistance role of the insulin receptor,IRS-I,GLUT-I and GLUT-4[J]. Am J Physiol,1997,272(6pt1):E1071-E1079.
|
[20]
|
Thirone A C,Carvalho C R,Brenelli S L,et al. Effect of chronic growth hormone treatment on insulin signal transduction in rat tissues[J]. Mol Cell Endocrinol,1997,130(1-2):33-42. doi: 10.1016/S0303-7207(97)00071-3
|
[21]
|
Robertson K,Kopchick J J,Liu J L. Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice[J]. Am J Physiol Endocrinol Metab,2006,291(3):E491-E498. doi: 10.1152/ajpendo.00378.2005
|
[22]
|
Mavalli M D,DiGirolamo D J,Fan Y,et al. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice[J]. J Clin Invest,2010,120(11):4007-4020. doi: 10.1172/JCI42447
|
[23]
|
Sasaki-Suzuki N,Arai K,Ogata T,et al. Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway[J]. J Biol Chem,2009,284(10):6061-6070. doi: 10.1074/jbc.M808282200
|
[24]
|
Dominici F P,Cifone D,Bartke A,et al. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice[J]. Am J Physiol,1999,277(3):E447-E454.
|
[25]
|
Takano A,Haruta T,Iwata M,et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes[J]. Diabetes,2001,50(8):1891-1900. doi: 10.2337/diabetes.50.8.1891
|
[26]
|
Ueki K,Fruman D A,Yballe C M,et al. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling[J]. J Biol Chem,2003,278(48):48453-48466. doi: 10.1074/jbc.M305602200
|
[27]
|
Del Rincon J P,Iida K,Gaylinn B D,et al. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue:Mechanism for growth hormone-mediated insulin resistance[J]. Diabetes,2007,56(6):1638-1646. doi: 10.2337/db06-0299
|
[28]
|
Ueki K,Yballe C M,Brachmann S M,et al. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase[J]. Proc Natl Acad Sci U S A,2002,99(1):419-424. doi: 10.1073/pnas.012581799
|
[29]
|
Mauvais-Jarvis F,Ueki K,Fruman D A,et al. Reduced expression of the murine p85αsubunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes[J]. J Clin Invest,2002,109(1):141-149. doi: 10.1172/JCI0213305
|
[30]
|
Taniguchi C M,Emanuelli B,Kahn CR. Critical nodes in signalling pathways:Insights into insulin action[J]. Nat Rev Mol Cell Biol,2006,7(2):85-96.
|
[31]
|
Yakar S,Setser J,Zhao H,et al. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice[J]. J Clin Invest,2004,113(1):96-105. doi: 10.1172/JCI200417763
|
[32]
|
Fruman D A,Mauvais-Jarvis F,Pollard D A,et al. Hypoglycaemia,liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha[J]. Nature Genetics,2000,26(3):379-382. doi: 10.1038/81715
|
[33]
|
Barbour L A,Mizanoor Rahman S,Gurevich I,et al. Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and inducesin vivoinsulin resistance associated with growth hormone excess[J]. J Biol Chem,2005,280(45):37489-37494. doi: 10.1074/jbc.M506967200
|
[34]
|
Kohn A D,Summers S A,Birnbaum M J,et al. Expression of a constitutively active akt ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation[J]. J Biol Chem,1996,271(49):31372-31378. doi: 10.1074/jbc.271.49.31372
|
[35]
|
Haruta T,Morris A J,Rose D W,et al. Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway[J]. J Biol Chem,1995,270(47):27991-27994. doi: 10.1074/jbc.270.47.27991
|
[36]
|
Yokota I,Hayashi H,Matsuda J,et al. Effect of growth hormone on the translocation of GLUT4 and its relation to insulin-like and anti-insulin action[J]. Biochim Biophys Acta,1998,1404(3):451-456. doi: 10.1016/S0167-4889(98)00077-9
|
[37]
|
Dalmolin C,Almeida D V,Figueiredo M A,et al. Expression profile of glucose transport-related genes under chronic and acute exposure to growth hormone in zebrafish[J]. Comp Biochem Physiol A Mol Integr Physiol,2018,221(18):1-6.
|
[38]
|
Schwartz J,Carter-Su C. Effects of growth hormone on glucose metabolism and glucose transport in 3T3-F442A cells:Dependence on cell differentiation[J]. Endocrinology,1988,122(5):2247-2256. doi: 10.1210/endo-122-5-2247
|
[39]
|
Imamura H,Morimoto I,Etoh S,et al. Skeletal muscle glucose transporter gene expression is not affected by injecting growth-hormone-secreting cells in young rats[J]. Diabetologia,1993,36(6):475-480. doi: 10.1007/BF02743260
|
[40]
|
Cartee G D,Bohn E E. Growth hormone reduces glucose transport but not GLUT-l or GLUT-4 in adult and old rats[J]. Am J Physiol,1995,268(5Pt1):E902-E909.
|
[41]
|
Napoli R,Cittadini A,Chow J C,et al. Chronic growth hormone treatment in normal rats reduces postprandial skeletal muscle plasma membrane GLUT1 content,but not glucose transport or GLUT4 expression and localization[J]. Biochem J,1996,315(Pt3):959-963.
|
[42]
|
Morita J,Hakuno F,Hizuka N,et al. Growth hormone(GH) or insulin-like growth factor(IGF-1)represses 11β-Hydroxysteroid dehydrogenase type 1(HSD1)mRNA expression in 3T3-L1 cells and its activity in their homogenates[J]. Endocrine Journal,2009,56(4):561-570. doi: 10.1507/endocrj.K08E-311
|
[43]
|
Li R S,Nakagawa Y,Liu Y J,et al. Growth hormone inhibits the 11β-hydroxysteroid dehydrogenase type 1 gene promoter activity via insulin-like growth factor I in HepG2 cells[J]. Hormone and Metabolic Research,2008,40(4):286-288. doi: 10.1055/s-2008-1058076
|
[44]
|
Stewart P M,Toogood A A,Tomlinson J W. Growth hormone,insulin-like growth factor-I and the cortisol-cortisone shuttle[J]. Horm Res,2001,56(Suppl 1):1-6.
|
[45]
|
Chowdhury S,Grimm L,Gong Y J,et al. Decreased 11beta-hydroxysteroid dehydrogenase 1 level and activity in murine pancreatic islets caused by insulin-like growth factor I overexpression[J]. PLoS One,2015,10(8):e0136656. doi: 10.1371/journal.pone.0136656
|
[46]
|
Mondok A,Varga I,Glaz E,et al. 11beta-hydroxysteroid dehydrogenase activity in acromegalic patients with normal or impaired carbohydrate metabolism[J]. Steroids,2009,74(9):725-729. doi: 10.1016/j.steroids.2009.03.003
|